Pueraria Lobata Tablets — Custom Manufacturing by CSK Biotech
CSK Biotech offers High Quality contract manufacturing for pueraria lobata tablets, combining GMP-certified production, comprehensive R&D, and global regulatory support for brands seeking high-quality kudzu root tablet solutions. Our integrated CDMO approach ensures reliable scale-up, consistent potency, and packaging flexibility so your product meets market needs and regulatory expectations with speed and confidence.
Explore our High Quality pueraria lobata tablets collection
Pueraria lobata, commonly known as kudzu root, has a long history in traditional wellness systems and is now widely formulated into tablets for modern supplement markets. Whether your product focus is botanical standardization, combination formulas, or targeted delivery, tablets are a cost-effective, stable format for daily dosing and consumer convenience. CSK Biotech supports single-ingredient and multi-ingredient tablet concepts with tailored excipients, controlled-release profiles, and taste-masking when needed.
Key practical advantages for brands and consumers include:
- Stable dosing and shelf life compared with many liquid botanical formats
- Compact packaging and predictable manufacturing yield at scale
- Clear labelability for standardized puerarin or isoflavone content
Why manufacturers and brands choose CSK Biotech
Founded in 2008, CSK Biotech is a high-tech enterprise focused on R&D and large-scale manufacturing of dietary supplements, health foods, and cosmetics. Our GMP-certified 2,000㎡ factory and seven advanced production lines support more than 1.5 billion tablets annually, backed by certifications including GMPC, FDA, HACCP, and ISO. For companies sourcing pueraria lobata tablets, this combination means consistent quality, traceable raw material handling, and the capacity to support both boutique and global roll-outs.
Our cooperative models are designed to meet different brand strategies:
- ODM: Market-oriented product innovation with turnkey formulation and packaging design.
- CDM: Tailor-made formulation development, including botanical standardization and excipient selection.
- OEM: Precise, formula-based production with strict adherence to client specifications and timelines.
Formulation, quality and supply chain confidence
High-quality pueraria lobata tablets begin with ingredient sourcing and end with validated stability. CSK Biotech’s offering covers every step: ingredient qualification, analytical method development, pilot runs, stability studies, and regulatory documentation. We integrate HACCP and ISO processes into daily operations to reduce contamination risks and ensure consistent potency across batches. For brands that require additional assurances, we provide third-party testing support and can accommodate bespoke packaging and serialization requirements to meet market-specific regulations.
Practical support for brand teams includes:
- Professional R&D and formulation development to optimize bioavailability and manufacturability
- Pilot testing and stability verification before full-scale production
- Regulatory registration assistance and marketing support to accelerate market entry
For inquiries or a confidential consultation on pueraria lobata tablet projects, contact CSK Biotech via our website at https://www.cskbiotech.com/ or email steve@cskbiotech.com. Our team will evaluate raw material specifications, target claims, and production timelines to propose an optimal cooperation model and costed roadmap.
FAQ
What are the common uses and benefits of pueraria lobata tablets?
Pueraria lobata tablets are typically used as botanical supplements that provide standardized isoflavones such as puerarin, which have been studied for supporting cardiovascular health, vascular function, and menopausal symptom management. As with all botanical supplements, consumer outcomes depend on extract standardization, dosage, formulation, and concurrent health factors. Brands should rely on validated clinical literature and clear label claims consistent with local regulations when communicating benefits.
How does CSK Biotech ensure quality and consistency for pueraria lobata tablets?
CSK Biotech follows a comprehensive quality framework: certified GMP facilities, qualified raw material suppliers, incoming identity and potency testing, validated manufacturing processes, and stability verification. Our ISO and HACCP systems reduce contamination risk, while analytical methods ensure each tablet batch meets predefined specifications for active constituents and microbiological safety. We also support third-party testing and regulatory documentation to meet market-specific requirements.
Can CSK Biotech create custom pueraria lobata tablet formulations or private-label products?
Yes. We offer three cooperation models—ODM for market-ready innovation, CDM for bespoke formulation work, and OEM for strict formula reproduction. Custom work includes selecting extract standardization (for example, target puerarin content), excipient systems to optimize disintegration and bioavailability, and specialized tablet profiles such as chewable or sustained-release forms. Pilot batches and stability studies are part of the development pathway to full-scale production.
What is the typical lead time and minimum order quantities for tablet manufacturing?
Lead times depend on project scope. For a standard OEM reproduction with materials and documentation supplied by the client, lead times can be shorter; full development projects (ODM/CDM) require additional R&D and pilot stages. Minimum order quantities vary by formulation complexity and packaging; CSK Biotech’s production capacity supports both small-scale launches and high-volume commitments. For precise timelines and MOQ, contact our sales team with your specification and target markets.
Are pueraria lobata tablets compliant with global regulatory standards and testing?
CSK Biotech manufactures under internationally recognized standards (GMPC, FDA-aligned practices, HACCP, ISO), and we can prepare regulatory dossiers and labeling to support compliance in many markets. Compliance also depends on target-market rules for botanical ingredients and permitted claims. We assist clients with stability data, certificate of analysis, and documentation needed for registration or import clearance, but final regulatory responsibility rests with the product owner or local distributor.
Contact
cskmanufacture
CSK Biotech Dietary Supplements
Guangzhou Changshengkang Biotechnology Co.,Ltd